Stock comparison
BECTON DICKINSON & CO is 18.3x more valuable than AtriCure, Inc. by market capitalization ($48.88 B vs $2.67 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
BDX is larger
BECTON DICKINSON & CO is 18.3x more valuable than AtriCure, Inc. by market capitalization ($48.88 B vs $2.67 B).
Market value leader
BDX
BECTON DICKINSON & CO is 18.3x more valuable than AtriCure, Inc. by market capitalization ($48.88 B vs $2.67 B).
Revenue leader
BDX
ATRC: $534.53M vs BDX: $21.84B.
Profit leader
BDX
ATRC: -$11.45M vs BDX: $1.68B.
Margin leader
BDX
ATRC: -2.1% vs BDX: 7.7% net margin.
| Metric | ATRC | BDX |
|---|---|---|
| Market cap | $2.67 B | $48.88 B |
| US-listed rank | #1914 | #326 |
| Revenue (latest FY) | $534.53M | $21.84B |
| Net income (latest FY) | -$11.45M | $1.68B |
| Net margin | -2.1% | 7.7% |
| P/E (trailing FY) | - | 29.1x |
| SEC filings | 1,528 | 3,027 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
BECTON DICKINSON & CO is 18.3x more valuable than AtriCure, Inc. by market capitalization ($48.88 B vs $2.67 B).
In their latest fiscal years, AtriCure, Inc. reported $534.53M in revenue while BECTON DICKINSON & CO reported $21.84B.
Full pages: AtriCure, Inc. and BECTON DICKINSON & CO, or browse the full rankings.